Perspective Therapeutics Inc (CATX)
2.24
-0.06
(-2.61%)
USD |
NYAM |
Mar 28, 10:57
Perspective Therapeutics Enterprise Value: -54.92M for March 27, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Allurion Technologies Inc | 39.41M |
Retractable Technologies Inc | -13.09M |
Xtant Medical Holdings Inc | 97.01M |
VolitionRX Ltd | 47.18M |
Catheter Precision Inc | 3.511M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -40.17M |
Total Expenses (Quarterly) | 20.90M |
EPS Diluted (Quarterly) | -0.61 |
Earnings Yield | -53.57% |
Normalized Earnings Yield | -26.79 |